Study title:
Sposto-R, Ertel-I-J, Jenkin-R-D, Boesel-C-P, Venes-J-L, Ortega-J-A, Evans-A-E, Wara-W, Hammond-D.
University of Southern California School of Medicine, Los Angeles.
The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.
Journal of neuro-oncology, {J-Neurooncol}, Jul 1989, vol. 7, no. 2, p. 165-77, ISSN: 0167-594X.Sposto-R, Ertel-I-J, Jenkin-R-D, Boesel-C-P, Venes-J-L, Ortega-J-A, Evans-A-E, Wara-W, Hammond-D.
University of Southern California School of Medicine, Los Angeles.
The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.
Journal of neuro...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|